Balaji Amines shares spike 10% on strong earnings growth

The company reported 29 percent year-on-year growth in consolidated profit at Rs 101.59 crore and the consolidated revenue saw a 44.1 percent increase to Rs 564.89 crore for December 2021 quarter
03-02-2022
Bigul

Q3FY22 Quarterly Result Announced for Balaji Amines Ltd.

Specialty Chemicals company Balaji Amines declares Q3FY22 result: Consolidated Q3FY22 Revenue up by 44% at Rs 565.83 Crore; EBITDA up by 35% at Rs 159.67 Crore; Net Profit up by 29% at Rs 101.59 Crore Revenue from Operations for Q3FY22 stood at Rs 565.83 crore, up by 44.11%, as compared to Rs 392.64 crore in Q3FY21. Total volumes stood at 27,589 MT for Q3FY22 as against 31,993 MT in Q3FY21. The revenue growth was muted sequentially as compared to previous quarter due to sluggish demand for few products - because few of our clients couldn’t procure Key Starting Materials (KSMs) for some of our matching products. At the same time, the company had to shut down the plants of DMF & Acetonitrile for a brief period to carry out the de-bottlenecking exercise, which were completed in the month of November 2021 Amines volumes stood at 6,460 MT Amines Derivatives volumes stood at 9,912 MT Specialty Chemicals volumes stood at 11,217 MT EBITDA for Q3FY22 was Rs 159.67 crore, up by 35.45%, as compared to Rs 117.88 crore in Q3FY21. EBITDA margin for Q3FY22 stood at 28.22% as against 30.02% in Q3FY21. The fall in operating margin was primarily due to lower operating leverage on account of dip in volume offtake PAT for Q3FY22 was Rs 101.59 crore, up by 28.74%, as compared to Rs 78.91 crore in Q3FY21. Diluted EPS for Q3FY22 stood at Rs 27.64 per equity share On the performance Mr. D. Ram Reddy, Managing Director, commented, “The demand remained sluggish due to the unavailability of KSMs for same of our matching products at our customers’ end in Q3FY22. However, this constraint is now over, and we are witnessing a substantial pick-up in these products. Our sales volumes were also affected on account of temporary shutdowns we had to undertake at our DMF and Acetonitrile plants for the debottlenecking exercise, which was completed in November 2021. As announced earlier, our capex for DMC plant under Phase 1 of our 90-acre Greenfield Project (Unit IV) is nearing completion and we hope to commence operations during Q1FY23. The capacity of this plant would be about 10,000 to 12,000 tons per annum. The company would be the sole manufacturer of this product in India and currently the annual domestic demand stands at about 8,000 to 9,000 tons which is completely met by imports. We are confident to achieve capacity utilization of 60-70% at our DMC plant in our first year of operation itself. DMC is used in the production of Polycarbonate and Lithium Batteries – the consumption of which will exponentially grow in India backed by various government incentives. Also, we see encouraging scope for exporting DMC to outside markets." Result PDF
03-02-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release in connection with Un-audited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December, 2021
02-02-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Announcement Under Regulation 30 (LODR)-Updates

Intimation of Appointment of Cost Auditors of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
02-02-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Submission Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31.12.2021

Submission of Un-audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December, 2021
02-02-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting held on 02/02/2022
02-02-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst / Institutional Investor meeting to discuss Q3 FY22 Earnings.
31-01-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31St December, 2021.

BALAJI AMINES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 ,inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for The Quarter and Nine Months Ended 31st December, 2021
25-01-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Shareholding for the Period Ended December 31, 2021

Balaji Amines Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
10-01-2022
Bigul

BALAJI AMINES LTD.-$ - 530999 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2021
03-01-2022
Next Page
Close

Let's Open Free Demat Account